| Mrs Aidah Esarey, MS, FAAA | |
|
301 W Poplar St, Ste 210, Walla Walla, WA 99362-2858 | |
| (509) 522-5825 | |
| (509) 529-3512 |
| Full Name | Mrs Aidah Esarey |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 35 Years |
| Location | 301 W Poplar St, Walla Walla, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285777102 | NPI | - | NPPES |
| 1285777102 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | LD00001071 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services - Washington | 2860552973 | 217 |
News Archive
Since the development of insulin to manage diabetes, pharmacists have longed to create an insulin pill. Past attempts have failed because insulin does not survive the harsh conditions of the gastro-intestinal system and cannot easily cross the GI wall.
Researchers at the University of Michigan School of Public Health and Medical School and collaborators at two other institutions will undertake the largest whole genome sequencing study funded to date, as they seek to better understand bipolar disorder and schizophrenia.
Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. According to a report in ACS' journal Molecular Pharmaceutics, the new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug.
Exposure for even fractions of a second to high-powered blue handheld laser devices can cause serious eye injuries, according to a study recently released online in Ophthalmology, the journal of the American Academy of Ophthalmology. The researchers have concluded that the wide availability of these devices, which are often marketed as toys, could lead to an epidemic of ocular injuries, and greater public awareness and government intervention should be encouraged.
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
› Verified 6 days ago
| Provider Name | Providence Health & Services - Washington |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922259738 PECOS PAC ID: 2860552973 Enrollment ID: O20081223000478 |
News Archive
Since the development of insulin to manage diabetes, pharmacists have longed to create an insulin pill. Past attempts have failed because insulin does not survive the harsh conditions of the gastro-intestinal system and cannot easily cross the GI wall.
Researchers at the University of Michigan School of Public Health and Medical School and collaborators at two other institutions will undertake the largest whole genome sequencing study funded to date, as they seek to better understand bipolar disorder and schizophrenia.
Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. According to a report in ACS' journal Molecular Pharmaceutics, the new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug.
Exposure for even fractions of a second to high-powered blue handheld laser devices can cause serious eye injuries, according to a study recently released online in Ophthalmology, the journal of the American Academy of Ophthalmology. The researchers have concluded that the wide availability of these devices, which are often marketed as toys, could lead to an epidemic of ocular injuries, and greater public awareness and government intervention should be encouraged.
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Aidah Esarey, MS, FAAA Po Box 34439, Seattle, WA 98124-1439 Ph: () - | Mrs Aidah Esarey, MS, FAAA 301 W Poplar St, Ste 210, Walla Walla, WA 99362-2858 Ph: (509) 522-5825 |
News Archive
Since the development of insulin to manage diabetes, pharmacists have longed to create an insulin pill. Past attempts have failed because insulin does not survive the harsh conditions of the gastro-intestinal system and cannot easily cross the GI wall.
Researchers at the University of Michigan School of Public Health and Medical School and collaborators at two other institutions will undertake the largest whole genome sequencing study funded to date, as they seek to better understand bipolar disorder and schizophrenia.
Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. According to a report in ACS' journal Molecular Pharmaceutics, the new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug.
Exposure for even fractions of a second to high-powered blue handheld laser devices can cause serious eye injuries, according to a study recently released online in Ophthalmology, the journal of the American Academy of Ophthalmology. The researchers have concluded that the wide availability of these devices, which are often marketed as toys, could lead to an epidemic of ocular injuries, and greater public awareness and government intervention should be encouraged.
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient's bone marrow is replaced by scar tissue.
› Verified 6 days ago
Diana Fitzgerald, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720 | |
Whitney Kathleen Jacky, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 104b E Main St, Walla Walla, WA 99362 Phone: 509-876-0555 Fax: 509-876-0556 | |
Mrs. Nicole Ann Kenny, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 77 Wainwright Dr, Audiology 240, Walla Walla, WA 99362 Phone: 509-525-5200 Fax: 509-527-3459 | |
Ms. Joanne Price, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 403 E Rose St, Walla Walla, WA 99362 Phone: 509-525-2759 Fax: 509-525-1998 | |
Mary Lou Yocum, M.A., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 403 E Rose St, Walla Walla, WA 99362 Phone: 509-525-5759 Fax: 509-525-1998 | |
Timothy J Davis, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 320 W Willow St, Walla Walla, WA 99362 Phone: 509-525-3720 |